Richard Chesworth, DPhil

Richard Chesworth, DPhil, is currently an Independent R&D Consultant who has more than 20 years of experience in the pharmaceutical and biotechnology industry. Richard has contributed to the research and development programs of nine different compounds entering clinical trials. Previously, he served as Chief Scientific Officer at Kymera Therapeutics Prior to joining Kymera, Richard was an Entrepreneur-In-Residence at Third Rock Ventures where he focused on building new drug discovery and development companies. Richard also served as Senior Vice President of Research at Epizyme, where he was responsible for pipeline activities from target selection to IND as well as non-clinical support of clinical candidates. Richard has also held positions at EnVivo (a.k.a. Forum Pharmaceuticals), Surface Logix, and Pfizer. Richard obtained a BSc in Chemistry from Imperial College of Science, Technology and Medicine at the University of London and a DPhil in Chemistry from the University of Oxford.